| Literature DB >> 35685201 |
Ainur Amanzholkyzy1, Gulaim Taskozhina2, Farida Balmaganbetova1, Azhar Zhexenova2, Roza Nurgaliyeva1.
Abstract
Background: The most common malignant tumor in women is breast cancer (BC). The ability of regulatory cells to inhibit cellular immune response as well as to participate in the modulation of antitumor immunity has attracted much interest of scientists. The purpose of this study was to assess the correlation between the specific and nonspecific vaginal immunity in women with BC.Entities:
Keywords: Biocenosis; Malignant Neoplasms Immunoediting; Normal Flora; Obligate Anaerobes; Vaginal Immunity
Year: 2021 PMID: 35685201 PMCID: PMC9127777 DOI: 10.47176/mjiri.35.174
Source DB: PubMed Journal: Med J Islam Repub Iran ISSN: 1016-1430
Comparative Analysis (Spearman's correlation) of Specific Immunity in Both Groups After Chemotherapy
| Markers |
|
| |
|---|---|---|---|
| Study Group | Control Group | ||
| Т-lymphocytes (CD3+CD19-) | 71.7 [66.3;76.7] | 71.4 [65.4;75.8]f | 0.055 |
| В-lymphocytes (CD3-CD19+) | 7.9 [3.7;12.2] | 10.4 [7.8;13.7] | 0.001 |
| Т-helpers (CD4+CD8+) | 40.7 [32.4;45.0] | 39.0 [32.1;43.7] | 0.036 |
| T-cytokines (CD4-CD8+) | 31.7[25.8;36.8] | 28.5[24.5;35.4] | 0.008 |
| IRI | 1.3[0.9;1.6] | 1.3[1.0;1.7] | 0.074 |
| CD3+HLA-DR+(activated Т- lymphocytes) | 8.7 [4.5;14.8] | 6.1 [2.0;13.0] | 0.003 |
| CD3-HLA-DR+ | 13.4 [9.8;15.4] | 13.6 [11.5;14.9] | 0.045 |
| NK(CD16+56+)-natural killers | 11.6[8.0;16.8] | 11.3[7.3;18.8] | 0.053 |
| Т-killers (CD3+/CD16+CD56+) | 5.8[3.3;9.0] | 6.4[4.5;10.0] | 0.003 |
Note: Me – median, 25% – lower quartile, 75% – upper quartile
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5Correlation Between Immune Markers and Representatives of Vaginal Microflora in Both Groups With Breast Cancer
|
|
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |
| T-cytotoxic (CD4-CD8+) | -0.2 | 0.5 | 0.5 | 0.5 | ||||||||
| T-helper (CD4+CD8-) | -0.4 | 0.3 | ||||||||||
| CD3-HLA-DR+ | 0.6 | -0.4 | ||||||||||
| CD3+HLA-DR+(activated Е-lymphocytes) | -0.3 | 0.5 | -0.3 | -0.6 | ||||||||
| Т-killers CD3+/CD16+56+ | 0.4 | |||||||||||
| B-lymphocytes (CD3-CD19+) | -0.4 | -0.3 | ||||||||||
| NK(CD16+56+)-natural killers | -0.5 | |||||||||||
| IRI | 0.3 | -0.5 | -0.2 | -0.6 | ||||||||
Note: P ≤0.001 was the significance level for all correlations.